Trials / Withdrawn
WithdrawnNCT00102154
An Investigational Drug Study in Healthy Adult Volunteers in a Model of Insomnia (0928-007)
A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Study of MK0928 in Healthy Adult Volunteers Participating in a 4-Hour Phase Advance Model of Transient Insomnia
- Status
- Withdrawn
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- H. Lundbeck A/S · Industry
- Sex
- All
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Accepted
Summary
A study to evaluate the safety and effectiveness of an investigational drug for insomnia (a sleep disorder).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0928, gaboxadol / Duration of Treatment: 10 months |
Timeline
- Start date
- 2005-01-01
- First posted
- 2005-01-24
- Last updated
- 2015-01-14
Source: ClinicalTrials.gov record NCT00102154. Inclusion in this directory is not an endorsement.